With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.166104-20-7,1-Boc-5-Aminoindole,as a common compound, the synthetic route is as follows.
To a solution of 2-bromo-3-((4-fluorophenyl)ethynyi)-6-methoxypyridine (1ntermediate 44, 531mg. 0867 mmol) in anhydrous toluene (9 rnL) was added XPhos (83 mg, 0.17 mmol), Pd2(dba)3(79 trig, 0088 mrnol), and potassium tert-butoxide (292 mg, 260 mmol). After 10 mimi. tert-butyi5-amino-i H-indole- I -carhoxylate (Intermediate ii, 201 trig. 0.867 mmnol) was added. The resultingsolution was refiuxed at 100 O(? for 3hr, then allowed to cool to 20 ¡ãC. The reaction was partitioned between EtOAc and water. The organic phase was separated, dried (MgSO4), filtered, and concentrated in vacuo, no deprotection necessary. Purification (FCC, Si02, 0percent to 30percent EtOAc/ heptanes) afforded the title compound (60 mg, 19percent) as a yellow solid. MS (ESI): mass caicd. forC22H,6FNO, 357.1; m/z found, 358 [M+Hr. ?H NMR (300 MHz, DMSO.-d6) oe 11.36 (s, iH, 7.53?7.42 (m, 3H), 7.41 ? 7.30 (m, 3H), 7.11 (t, J= 8.8 Hz, 2H), 6.92 (d, J= 8.5 Hz, 1H?), 6.85 (s, 1H?), 6.57 (d, J= 8.8 Hz, IH), 6.47 (s, IH), 3.90 (s, 3H)., 166104-20-7
The synthetic route of 166104-20-7 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; JANSSEN PHARMACEUTICA NV; BERRY, Cynthia G.B.; CHEN, Gang; JOURDAN, Fabrice Loic; LEBOLD, Terry Patrick; LIN, David Wei; PENA PINON, Miguel Angel; RAVULA, Suchitra; SAVALL, Bradley M.; SWANSON, Devin M.; WU, Dongpei; ZHANG, Wei; AMERIKS, Michael K.; (407 pag.)WO2016/176460; (2016); A1;,
Indole alkaloid derivatives as building blocks of natural products from?Bacillus thuringiensis?and?Bacillus velezensis?and their antibacterial and antifungal activity study
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles